Mostrar el registro sencillo del ítem
dc.contributor.author | Martiáñez-Vendrell, Xavier | |
dc.contributor.author | Jiménez, Alfons | |
dc.contributor.author | Vásquez, Ana | |
dc.contributor.author | Campillo, Ana | |
dc.contributor.author | Incardona, Sandra | |
dc.contributor.author | González, Raquel | |
dc.contributor.author | Gamboa Vilela, Dionicia Baziliza | |
dc.contributor.author | Torres Fajardo, Katherine Jessica | |
dc.contributor.author | Oyibo, Wellington | |
dc.contributor.author | Faye, Babacar | |
dc.contributor.author | Macete, Eusebio | |
dc.contributor.author | Menéndez, Clara | |
dc.contributor.author | Ding, Xavier C. | |
dc.contributor.author | Mayor, Alfredo | |
dc.date.accessioned | 2020-07-14T00:02:33Z | |
dc.date.available | 2020-07-14T00:02:33Z | |
dc.date.issued | 2020 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/8337 | |
dc.description.abstract | BACKGROUND: Malaria diagnostics by rapid diagnostic test (RDT) relies primarily on the qualitative detection of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and Plasmodium spp lactate dehydrogenase (pLDH). As novel RDTs with increased sensitivity are being developed and implemented as point of care diagnostics, highly sensitive laboratory-based assays are needed for evaluating RDT performance. Here, a quantitative suspension array technology (qSAT) was developed, validated and applied for the simultaneous detection of PfHRP2 and pLDH in a variety of biological samples (whole blood, plasma and dried blood spots) from individuals living in different endemic countries. RESULTS: The qSAT was specific for the target antigens, with analytical ranges of 6.8 to 762.8 pg/ml for PfHRP2 and 78.1 to 17076.6 pg/ml for P. falciparum LDH (Pf-LDH). The assay detected Plasmodium vivax LDH (Pv-LDH) at a lower sensitivity than Pf-LDH (analytical range of 1093.20 to 187288.5 pg/ml). Both PfHRP2 and pLDH levels determined using the qSAT showed to positively correlate with parasite densities determined by quantitative PCR (Spearman r = 0.59 and 0.75, respectively) as well as microscopy (Spearman r = 0.40 and 0.75, respectively), suggesting the assay to be a good predictor of parasite density. CONCLUSION: This immunoassay can be used as a reference test for the detection and quantification of PfHRP2 and pLDH, and could serve for external validation of RDT performance, to determine antigen persistence after parasite clearance, as well as a complementary tool to assess malaria burden in endemic settings. | en_US |
dc.language.iso | eng | |
dc.publisher | BioMed Central | |
dc.relation.ispartofseries | Malaria Journal | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | Histidine-rich protein 2 | en_US |
dc.subject | Luminex | en_US |
dc.subject | Malaria | en_US |
dc.subject | Parasite lactate dehydrogenase | en_US |
dc.subject | Quantitative suspension array technology | en_US |
dc.subject | Rapid diagnostic test | en_US |
dc.title | Quantification of malaria antigens PfHRP2 and pLDH by quantitative suspension array technology in whole blood, dried blood spot and plasma | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1186/s12936-019-3083-5 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.07 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.08 | |
dc.relation.issn | 1475-2875 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |